A randomised parallel arm comparative clinical study to evaluate the efficacy of rasona taila matrabasti and tila taila matrabasti in the management of kashtartava.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To evaluate the efficacy of Rasona Taila Matra Basti in Kashtartava.
研究概览
简要总结
In Ayurvedic classics, all gynaecological problems are described under the broad tittle of Yonivyapada, Though the disease, Kashtartava is not explained as a separate disease, it is described as symptom as anciently females were not suffering much from this problem due to Rutucharya and Rajaswalacharya. It is a symptom of various Yonivyapadas specially Udavartini Yonivyapad, Vatala Yonivyapad and Sannipatiki Yonivyapada. On the basis of signs and symptoms, it can be compared with Dysmenorrhoea, which is not associated with any identifiable pelvic pathology. Dysmenorrhoea or pain during menstruation is probably the most frequent of all symptoms seen in gynaecological disorders, it can be explained as a cramping pain accompanying menstruation. Genetic factors, exertion and activity patterns affect prevalence and severity of dysmenorrhoea. Various studies in India revealed that the prevalence of dysmenorrhoea varies from 33 to 79.67%. However, the true incidence and prevalence of dysmenorrhoea are not clearly established in India and also exact characteristics are also not clearly known. Hence this topic is selected to compare the efficacy of Rasona Taila Matrabasti and Tila Taila Matrabasti in Kashtartava. The study will be conducted for 3 conservative menstrual cycle. There will be follow up on every 5th day of 1st, 2nd and 3rd menstrual cycle.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 13.00 Year(s) 至 25.00 Year(s)(—)
- 性别
- Female
入选标准
- •Irrespective of marital status of age 13-25 years.
- •Participant with regular menstrual cycle.
- •Participant with painful menses for at least 2 consecutive menstrual cycles.
排除标准
- •Congenital anomalies of uterus or ovaries which affects her menstruation.
- •Participant with any uterine pathology (fibroid, cervical polyp, adenomyosis, etc).
- •Participant on hormonal therapy (oral contraceptive) or using an IUCD, PCOS, Anaemia.
- •Participant having Parikartika, Arsha.
- •Participant with known case of Diabetes Mellitus, Hypertension, Hypothyroid.
结局指标
主要结局
To evaluate the efficacy of Rasona Taila Matra Basti in Kashtartava.
时间窗: 8 consecutive days before expected date of menstruation (For 3 consecutive cycles)
次要结局
- To Study the safety of Rasona & Tila Taila Matrabasti in the management of Kashtartava(3 months)
- To evaluate the efficacy of Til taila matrabasti in Kashtartava(8 consecutive days before expected date of menstruation (For 3 consecutive cycles))
研究者
Dr Prerna Jain
Seth Govindji Raoji Ayurved Mahavidyalaya Solapur
